Skyepharma raises €112m for buy-back
Pharmaceutical firm Skyepharma launched a buy-back of its 6.5% 2024 bonds this week after completing a £112m capital raise.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: